, etc. In Q2-2023, there was an increase in cost of sales and services by 41.3%, which was higher than the change in revenue compared to the Q1-2023, which equaled to 35.4% due to many delivered projects
income – Cost of sales and services (does not include other income) Q3 2019 Q3 2018 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and service income 219.09 301.56 -82.47 -27% Other income
- 2019 Balance by Quarter Change Q2–19 Q1–19 Q2–18 Q2–19 VS Q1–19 Q2–19 VS Q2–18 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,730.1 1,266.8 1,029.9 463.3 36.6 700.2 68.0 Total Operating Expenses
from change in fair value of economic trees in the consolidated statement of comprehensive income of this year. 8. Finance cost 7.28 Million Baht decrease from the last year 3.90 Million Baht or 34.92
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
or 27.27 percent decreased by following details; Cost of goods sold as amount of 282.16 Million Baht as 99.25 Million Baht decreased or 26.02 percent when compared to same period of previous year of
DATE: 283/99 อาคารโฮมเพลสออฟฟิศบิลดิง้ ช้ัน 20 ซอยสุขุมวทิ 55 ถนนสุขุมวทิ แขวงคลองตันเหนือ เขตวฒันา กรุงเทพมหานคร 10110 NPP. 043/2017 15 August 2017 Subject Clarify the performance change of over 20
, decrease Baht 0.59 million or 6.08%, both period not very difference. 2. Cost of sale , Profit margin In Q3/2017 the company had cost of sale Baht 85.71 million compare with the same period of previous year
(13.7) 815.4 902.2 (9.6) Total Expenses (Million Baht) Quarterly Change Six-month End June 30, Change 2/2019 2/2018 % 2019 2018 % Cost of goods sold 285.6 360.7 (20.8) 542.9 621.2 (12.6) Temporary
Nine-month End September 30, Change 3/2018 3/2017 % 2018 3/2018 3/2017 Cost of goods sold 349.3 333.1 4.9 982.7 983.9 (0.1) Temporary shutdown expenses 12.9 45.7 (71.8) 38.1 118.4 (67.8) Selling expenses